Dewi P. I. Moonen

Dewi P. I. Moonen

Auto-generated profile, based on publicly available information

Dewi P. I. Moonen

European Molecular Biology Laboratory (EMBL), Genome Biology Unit, Heidelberg, Germany

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 March 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
DMDewi P. I. Moonen
Dewi P. I. Moonen
ACAnnique Claringbould
Annique Claringbould
AGAndreas R. Gschwind
Andreas R. Gschwind
SSStefan Schrod
Stefan Schrod
JBJana Braunger
Jana Braunger
LSLars M. Steinmetz
Lars M. Steinmetz
CD4+ T cells harbor a disproportionate enrichment of immune disease risk loci and represent the primary cellular context for immune disease biology, yet the genes and regulatory programs these variants affect remain largely unknown. We combined targeted Perturb-seq of 1,032 cis -regulatory elements (CREs) overlapping 4,724 variants across 14 immune diseases with genome-wide Perturb-seq of all expressed genes in primary human CD4+ T cells, spanning 4.1 million cells. We identified 626 CRE-gene pairs, and connected CRE targets to downstream regulatory cascades. At the TYK2 and DEXI /CLEC16A loci, we resolved target genes and linked noncoding variants to inflammatory and metabolic programs. Across diseases, we revealed that dispersed variants converged on shared and disease-specific programs. Our work provides a framework for tracing variant-to-CRE-to-gene-to-network in disease-relevant primary cells.

26 May 2026 in Nature Protocols
Verified
Journal Article
Closed access
DMDewi P. I. Moonen
Dewi P. I. Moonen
DSDaniel Schraivogel
Daniel Schraivogel
AGAndreas R. Gschwind
Andreas R. Gschwind
LSLars M. Steinmetz
Lars M. Steinmetz